Publications

Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy

Schett G, Wirsching A, Rothe T, Visconti V, Kramer N, Metzler M, Krickau T, Kirschen GW, Landau D, Elgarten C, Majithia V, De Langhe E, Vandenberghe P, Maurer B, Amoura Z, Simon D, Krönke G, Gergely P, Fernandes M, Shisha T, Law BM, Koegel A, Chang DJ, Mackensen A, Müller F, Hagen M.

N. Engl. J. Med. 2026 July. doi: 10.1056/NEJMc2607737

Game of microbes: a wildling’s guide

Bruno P, Rosshart SP.

Trends Microbiol. 2026 May. doi: 10.1016/j.tim.2025.12.017

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

Müller F, Hagen M, Wirsching A, Kharboutli S, Aigner M, Völkl S, Kretschmann S, Tascilar K, Taubmann J, Bucci L, Raimondo MG, Bergmann C, Rothe T, Corte G, Tur C, Muñoz L, Böltz S, Schuster L, Hartmann F, Garantziotis P, Spörl S, Vasova I, Gerbitz A, Spriewald B, Kiener H, Giannarelli D, Locatelli F, D’Agostino M-A, Hanssens L, Miltenyi S, Bozec A, Grieshaber-Bouyer R, Mackensen A, Schett G.

Nat. Med. 2026 January. doi: 10.1038/s41591-025-04185-6